CanCURE
The Canadian HIV Cure Enterprise (CanCURE) is a research collaboratory focused on studying HIV persistence during antiretroviral therapy and developing strategies towards a sustainable HIV remission. Our innovative scientific program is supported by the Canadian Institutes of Health Research (CIHR).
CanCURE Photo Gallery
CanCURE AGM 2019 - Group Photo
CanCURE 2019 Key Note Speaker
CanCURE AGM 2019 Public Session
CanCURE AGM 2019 Poster Session
CanCURE AGM 2019 Poster Session
CanCURE AGM 2019 Poster Session
Dr. Brendan Bell Presenting at AGM, Oct 19th, 2017, IRCM, Montreal
Annual General Meeting, Oct 19-20th, 2017, IRCM, Montreal
From left to right: Tomas Raul Wiche Salinas (Centre hospitalier de l’Université de Montréal Research Center, CRCHUM), Marta Massanella (CRCHUM), Éric A Cohen (IRCM), Segen Kidane (University of Toronto), Dr. Alan Cochrane (University of Toronto), Dr. Petronela Ancuta (CRCHUM), and Dr. Nicolas Chomont (CRCHUM).
University of Toronto, 2017
Available Positions
Research Assistant or Associate
Available at the Research Institute of McGill University Health Centre (RI-MUHC) to work on CIHR-funded research studies on HIV immunology. The candidate will be supervised by Dr Cecilia Costiniuk, Associate Professor in Infectious Diseases at McGill.
Postdoctoral Fellow
Available at the Research Institute of McGill University Health Centre (RI-MUHC) to work on CIHR-funded research studies on HIV immunology. The candidate will be supervised by Dr Cecilia Costiniuk, Associate Professor in Infectious Diseases at McGill.
Postdoctoral Fellow
Human Immunodeficiency Virus (HIV)-host interactions governing HIV persistence in different models of humanized mice. Dr. Eric Cohen, Montreal Clinical Research Institute (IRCM, Montreal)
Research Assistant or Associate
Department of Biological Sciences, Université du Québec à Montréal (UQAM), Canada Research Chair in Immuno-virology, Dr Jenabian
Postdoctoral Fellow
Laboratory of Dr Mohammad-Ali Jenabian, the holder of the Canada research chair in Immuno-Virology, at the Department of Biological Sciences, University of Quebec at Montreal (UQAM)
Publications
Fert et al. Targeting Th17 cells in HIV-1 remission / cure interventions. Trends in Immunology. July 2022
Tremblay et al. Bryostatin-1 Decreases HIV-1 Infection and Viral Production in
Human Primary Macrophages. Journal of Virology. February 2022
Murooka et al. T cell migration potentiates HIV infection by
enhancing viral fusion and integration. Cell Reports. February 2022
Salinas et al. Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth. PNAS. November 2021
Planas et al. Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy. EBioMedicine. March 2021
Routy et al. Beyond the Absence of CD4 T-Cell Count: A Novel Genetic CD4 T-Cell Deficiency Disorder With a Contingency Plan. J Infect Dis. February 2021
Peng et al. Differences in HIV burden in the inflamed and non-inflamed colon from a person living with HIV and ulcerative colitis. J Virus Erad. February 2021
Abdel-Mohsen et al. Recommendations for measuring HIV reservoir size in cure-directed clinical trials. Nature Med. September 2020
Gantner et al. Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART. Nature Communications. August 2020